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Prenatal nicotine exposure has been linked to attention deficit hyperactivity disorder and cognitive impairment, but the sites of action for
these effects of nicotine are still under investigation. High-affinity nicotinic acetylcholine receptors (nAChRs) contain the2 subunit and
modulate passive avoidance (PA) learning in mice. Using an inducible, tetracycline-regulated transgenic system, we generated lines of
mice with expression of high-affinity nicotinic receptors restored in specific neuronal populations. One line of mice shows functional2
subunit-containing nAChRs localized exclusively in corticothalamic efferents. Functional, presynaptic nAChRs are present in the thala-
mus of these mice as detected by nicotine-elicited rubidium efflux assays from synaptosomes. Knock-out mice lacking high-affinity
nAChRs show elevated baseline PA learning, whereas normal baseline PA behavior is restored in mice with corticothalamic expression of
these nAChRs. In contrast, nicotine can enhance PA learning in adult wild-type animals but not in corticothalamic-expressing transgenic
mice. When these transgenic mice are treated with doxycycline in adulthood to switch off nAChR expression, baseline PA is maintained
even after transgene expression is abolished. These data suggest that high-affinity nAChRs expressed on corticothalamic neurons during
development are critical for baseline PA performance and provide a potential neuroanatomical substrate for changes induced by prenatal
nicotine exposure leading to long-term behavioral and cognitive deficits.
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Introduction
The comorbidity of prenatal nicotine exposure with psychiatric
disorders and cognitive impairment suggests that nicotinic ace-
tylcholine receptors (nAChRs) may play a role in the etiology of
these disorders. In utero exposure to nicotine can increase the risk
of attention deficit hyperactivity disorder (ADHD), lower IQ,
and conduct disorder later in life (Ernst et al., 2001; Wakschlag et
al., 2002). Determining the nAChR subtypes and the neuroana-
tomical loci responsible for these effects is difficult using tradi-
tional pharmacological approaches because of the large number
of nAChR subtypes, their overlapping pharmacological profiles,
and their wide distribution in the brain. The thalamus has been
implicated in learning and memory, attention, arousal, and emo-
tionality (Masterman and Cummings, 1997; Kalivas et al., 1999).
In addition, the thalamus contains the highest density of high-
affinity nAChRs in the brain (composed predominantly of the4
and 2 nAChR subunits) (Zoli et al., 1998), but virtually nothing
is known about the function of nAChRs in this region. There are
two main neuronal types in thalamus: GABAergic interneurons
and glutamatergic thalamocortical relay neurons (Guillery and
Sherman, 2002). Glutamatergic sensory projections, glutamater-
gic projections from layer VI of the cortex, and cholinergic pe-
dunculopontine projections all synapse onto thalamic neurons
(Hallanger et al., 1987). Functional nAChRs are present at several
levels of this system on both cell bodies and terminals (Le´na and
Changeux, 1997; Lu et al., 1998; Corrigall et al., 1999). The en-
richment of high-affinity nAChRs in this region make it a poten-
tial target for developmental changes caused by alterations in
nicotinic receptor function.
Passive avoidance (PA) is a fear-associated learning test sensi-
tive to manipulations of the cholinergic system and a model for
emotional learning in humans. Cholinergic deafferentation of
thalamus in rodents, as in thiamine-deficient rats with reduced
choline-acetyl-transferase levels in thalamus (and other brain ar-
eas), is correlated with impairments in PA learning (Nakagawasai
et al., 2000). Senescence accelerated mice also have lower levels of
acetylcholine in thalamus and hypothalamus and show impaired
PA performance that is rectified by acute, pretrial administration
of nicotine (Meguro et al., 1994). 2 nAChR subunit knock-out
(2 ko) mice lack all high-affinity binding for nicotine and show
abnormally high baseline PA and no improvement in learning as
a result of post-training nicotine administration when compared
with wild-type siblings (Picciotto et al., 1995). To identify where
in the brain nicotinic receptors exert their actions on PA learning,
transgenic mice with temporally and spatially restricted expres-
sion of high-affinity nAChRs were generated and tested in PA.
These mice were used to identify the nAChR subtypes and neu-
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ronal populations that appear critical for the long-term behav-
ioral consequences of genetic or pharmacological manipulations
of nicotinic neurotransmission.
Materials and Methods
Animals. The cDNA encoding the 2 subunit was generated by reverse
transcription (RT)-PCR from mouse brain mRNA (5, TTT AAG CTT-
GCG CGG CTT CAG CAC CAC GGA CAG CGC; 3, TTT ACT AGT-
TCC ACC CAA TAC TAC TGA ACC) and subcloned into pTet-splice
(Invitrogen, Gaithersburg, MD). The plasmid was sequenced, and the
band containing the Tet-2 construct and SV40 3 untranslated region
was excised, purified by gel electrophoresis, and microinjected into
B6SJL oocytes (Yale University Transgenic Facility). Founder mice car-
rying the transgene were crossed with Line A NSE-tTA mice on the ICR
background (Chen et al., 1998; Kelz et al., 1999) and 2 ko mice on the
C57BL/6J background (Picciotto et al., 1995). C57BL/6J mice were ob-
tained from The Jackson Laboratory (Bar Harbor, ME). Genotyping was
performed by PCR on phenol-extracted tail DNA. Mice were crossed to
generate 2 ko or 2 heterozygote (2 het) offspring with at least one
copy of the Tet-2 and NSE-tTA transgenes. Litters of mice on a mixed
genetic background of 2 wild-type (wt), 2 het, and 2 ko genotype
with copies of one or both of the transgenes were used for behavioral
experiments. 2 ko mice with both transgenes (2 tr) expressed the 2
subunit inducibly in different brain regions. 2 tr, 2 wt, and het mice
with or without the transgenes (wild type), and 2 ko mice with no
transgenes or only a single transgene (2 ko) were compared. Mice were
group housed with a maximum of five per cage in a colony room main-
tained at 22°C on a 12 hr light/dark cycle, with lights on at 7:00 A.M. Food
and water were available ad libitum. All animal procedures were in strict
accordance with NIH Care and Use of Laboratory Animals Guidelines and
were approved by the Yale Animal Care and Use Committee.
PA learning. Testing was performed in a mouse PA chamber (Ugo
Basile, Comerio, Italy). On day 1, the mouse was placed in the light
chamber and allowed to move freely between the two compartments for
5 min. On day 2, the mouse was placed in the light chamber, and latency
to enter the dark chamber was measured. After entry into the dark cham-
ber, the door between compartments closed, and a 2 sec electric shock
(0.2 mA) was administered through the grid floor. The animal was re-
moved from the apparatus, given an intraperitoneal injection (10l/gm)
of 0.9% saline or 10 g/kg nicotine bitartrate (concentration calculated
as free base), and returned to a holding cage. On day 3, mice were again
placed in the light chamber, and time to enter the dark chamber was
recorded. Mice used in the initial passive avoidance experiment were
aged from 2 to 9 months. No differences in PA behavior were seen with
age. Another cohort of mice (aged 4 –12 months at testing) was divided
into two groups (balanced by genotype, sex, and age), and half were given
doxycycline (dox) in their drinking water (100 g/ml) for 5 to 7 weeks
before PA testing.
Shock reactivity test. Shock reactivity was measured as described previ-
ously (Caldarone et al., 2000). Mice were given a series of 1 sec shocks
starting at 0.05 mA and increasing to 1 mA in increments of 0.05 mA,
with a 19 sec intershock interval. Mice were scored by two observers for
flinch (any observable reaction to the shock), run, jump, or vocalization
reactions. For each animal, the experiment was stopped when the mouse
had displayed all four reactions. Mean current thresholds to evoke each
response were calculated and averaged between observers.
In situ hybridization and equilibrium binding. Mice were decapitated,
and brains were removed, frozen on dry ice, and stored at 80°C. Sec-
tions (12m) were cut at the cryostat, thaw mounted onto chrom-alum-
coated slides [0.5% chromium (III) phosphate– 0.5% gelatin] for radio-
ligand binding or charged slides (Fisherbrand Superfrost/Plus; Fisher
Scientific, Pittsburgh, PA) for in situ hybridization. Sections were dried at
room temperature for 20 min and stored at80°C. The large intracellu-
lar loop of the 2 subunit (amino acids 338 – 456) was subcloned into
pBluescript. Antisense and sense cRNA probes were transcribed with T7
or SP6 RNA polymerase in the presence of [ 35S]UTP (NEN, Boston, MA)
and purified through RNA mini-quick-spin columns (Roche, Indianap-
olis, IN). Brain sections were postfixed in 4% paraformaldehyde in 1
PBS (in mM: 1 KH2PO4, 10 Na2HPO4, 1.37 NaCl, and 2.7 KCl, pH 7.4),
acetylated for 15 min in 0.1 M tetraethylammonium and 0.25% acetic
anhydride, and dehydrated through an ethanol series. Slides were hybrid-
ized overnight at 60°C (10 6 cpm per slide), washed in 2 SSC (0.3 M
sodium acetate and 0.03 M sodium citrate), treated with 20 g/ml
RNaseA (Roche), washed in descending concentrations of SSC (to 0.1)
at 55°C, rinsed with water, dried, and exposed to 3H-Hyperfilm (Amer-
sham Biosciences, Arlington Heights, IL) for 15 d.
For radioligand binding, sections were thawed at room temperature
and incubated with 200 pM [ 125I]A85380 for 30 min in 50 mM Tris-HCl,
pH7.4, washed twice in the same buffer, dried, and exposed to 3H-
Hyperfilm for 2–7 d.
Tissue preparation and rubidium efflux. Mice were killed, and brain
regions were dissected on ice. Samples were homogenized in cold iso-
tonic sucrose (0.32 M sucrose with 5 mM HEPES, pH 7.5) in a tissue
grinder with 16 strokes by hand. Homogenates were centrifuged at
12,000 g for 20 min, and pellets were resuspended in different buffers
depending on the following assay. Rubidium efflux experiments were
performed as described previously (Marks et al., 2002). Briefly, homog-
enized and centrifuged tissue was resuspended in buffer A (in mM: 140
NaCl, 1.5 KCl, 2 CaCl2, 1 MgSO4, 20 glucose, and 20 HEPES hemiso-
dium, pH 7.5). Aliquots (25 l) were incubated with 4 Ci of [ 86Rb]
for 30 min at 22°C in a final volume of 35 l. Uptake was terminated by
filtration of each sample onto a Gelman A/E glass fiber filter under gentle
vacuum and washing once with 0.5 ml of buffer A. The washed filters
were transferred to a polypropylene platform and superfused with buffer
B (135 mM NaCl, 5 mM CsCl, 1.5 mM KCl, 1 mM MgSO4, 2 mM CaCl2, 20
mM glucose, 50 nM tetrodotoxin, 1 M atropine, 20 mM HEPES hemiso-
dium, and 0.1% bovine serum albumin, pH 7.5). Buffer was applied at a
rate of 2.5 ml/min and was actively removed with a second peristaltic
pump set for a flow rate of 3.2 ml/min. The buffer was pumped through
a 200 l Cherenkov cell in -RAM Radioactivity HPLC detector (IN/US
Systems, Tampa, FL) to allow continuous monitoring of radioactivity.
Samples were stimulated by diverting the application buffer through a
200 l loop containing the test solution (30 M nicotine). Stimulation
time was 5 sec. Baseline efflux was calculated using points before and
after stimulation. Magnitude of [ 86Rb] efflux was calculated as stimu-
lation above basal and normalized to basal efflux to allow comparison
among regions and genotypes.
Epibatidine binding. Epibatidine binding was performed as described
previously (Marks et al., 2002). Samples were incubated in a 96-well
polystyrene plate for 2 hr at 22°C. Final incubation was in 30 l of
binding buffer. Binding reactions (200 pM [ 125I] epibatidine) were ter-
minated by filtration onto Gelman A/E glass fiber paper that had been
treated with 0.5% polyethylenimine. Samples were washed six times with
cold load buffer. Bound ligand was quantified using a Packard Cobra
Gamma Counter. Counting efficiency was 85%. Blanks were determined
with 100 M nicotine, and all results presented are specific binding.
GABA release. [ 3H]GABA release from synaptosomes was performed
as described previously (Lu et al., 1998). Homogenates from cortex, thal-
amus, hippocampus, and striatum were centrifuged at 12,000 g for 20
min. The resulting crude synaptosomal pellet was resuspended in uptake
buffer (in mM: 128 NaCl, 2.4 KCl, 1.2 KH2PO4, 1.2 MgSO4, 3.2 CaCl2, 25
HEPES, and 10 glucose, pH 7.5) and incubated with 1 mM aminooxyace-
tic acid at 37°C for 10 min. [ 3H]GABA (0.1 M) and unlabeled GABA
(0.25 M) were added and incubated 10 min at 37°C. Aliquots were
collected onto glass fiber filters and washed with 0.5 ml of perfusion
buffer (119 mM NaCl, 3.6 mM KCl, 1.2 mM MgSO4, 10 mM CsCl, 3.2 mM
CaCl2, 25 mM HEPES, 10 mM glucose, and 0.1% BSA, pH 7.5). Perfusion
buffer was pumped over synaptosomes at 1.8 ml/min (RT). Release was
stimulated by a 12 sec exposure to 30 M L-nicotine. Data (as counts per
minute released per fraction) were corrected for baseline release from
fractions collected before and after the agonist stimulation. Data were
then normalized to baseline, and fractions in which release exceeded
baseline by 10% or more were summed. Units of release are as fraction of
baseline.
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Results
Inducible, region-specific expression of2
subunit-containing nAChRs
Transgenic mice were generated that express the 2 subunit of
the nAChR under the control of a tetracycline-regulated pro-
moter (TetOp-2). Founder mice were crossed with 2 ko mice
carrying a transgene encoding the neuron-specific enolase pro-
moter driving expression of the tetracycline transactivator (NSE-
tTA). In 2 tr mice, all 2 subunit-containing nAChRs in the
brain were expressed from the tetracyline-regulatable transgene.
Equilibrium binding using the nicotinic agonist [ 125I]epibatidine
in brain slices identified three TetOp-2 lines of mice with in-
creased densities of high-affinity binding sites (data not shown).
Region-specific patterns of binding were similar in all three lines,
and one line was picked for further characterization. This line was
crossed to three different NSE-tTA founder lines (Chen et al.,
1998; Kelz et al., 1999). Equilibrium binding studies using
[ 125I]A85380, a nicotinic ligand specific to 2-containing
nAChRs (Mukhin et al., 2000), showed distinct patterns of ex-
pression in each of the NSE-tTA lines (Fig. 1). High-affinity nic-
otinic binding in 2 tr(CT) mice was restricted to cortex and
thalamus. 2 tr(VN) mice expressed high-affinity nAChRs in the
optic tract, visual nuclei of the thalamus, and superior colliculus.
2 tr(VTA) mice showed high-affinity nicotinic binding pre-
dominantly in nucleus accumbens, substantia nigra, ventral teg-
mental area, and striatum. In contrast,2 het siblings of the2 tr
mice showed A85380 binding throughout the brain, and 2 ko
mice had no detectable binding. As a result of the enrichment of
nicotine binding in thalamus and cortex in the 2 tr(CT) trans-
genic mice, this line was selected for further characterization in
neurochemical and behavioral paradigms.
Inducible expression in2 tr(CT) mice is restricted to
corticothalamic projection neurons
Nicotinic ligand binding was performed on membranes isolated
from several brain regions to provide a quantitative measure of
high-affinity nAChRs expressed in 2 tr(CT) mice (Fig. 2A).
There was a clear effect of 2 subunit gene dosage on epibatidine
binding in most brain areas across 2 wt, het, and ko mice, as has
been reported previously (Marks et al., 1999); however, 2
tr(CT) mice showed significant epibatidine binding in the cortex
and thalamus only. In situ hybridization was performed using the
intracellular loop region of the2 subunit as a probe in2 tr(CT)
mice. 2 subunit mRNA was detected specifically in layer VI of
the cerebral cortex, CA1, and dentate gyrus of the hippocampal
formation and throughout the dorsal striatum, but no specific
hybridization was seen in the thalamus (Fig. 2B). This pattern is
similar to that seen for other genes of interest driven by the same
NSE-tTA line (Chen et al., 1998; Kelz et al., 1999). Ectopic expres-
sion of the 2 subunit transgene in cells not normally expressing
the heteromeric nAChRs does not result in the production of
assembled nAChRs or high-affinity nicotinic radioligand binding
because the 2 subunit can only form a functional channel in the
presence of its partner subunits (Luetje and Patrick, 1991). The
equilibrium binding data coupled with the in situ hybridization
studies suggest that 2 tr(CT) mice express functional high-
affinity nAChRs only in corticothalamic projection neurons.
Functional characterization of2 nAChRs in
corticothalamic terminals
To confirm that nicotinic binding in the thalamus represents
functional, terminal nAChRs and to identify the neurotransmit-
ter released from these neurons, synaptosomal fractions were
collected from several brain areas and were assayed for rubidium
[ 86Rb] efflux (Fig. 3A) and [ 3H]GABA release (Fig. 3B). The
[ 86Rb] efflux assay measures the opening of functional nico-
tinic receptor channels in synaptosomes in response to nicotine
stimulation (Marks et al., 1995). The expected gene dosage re-
sponse in [ 86Rb] efflux stimulated by nicotine was seen across
2 wt, het, and ko mice (Fig. 3A) (Marks et al., 1999). A signifi-
cant increase in [ 86Rb] efflux was seen in the thalamus of 2
tr(CT) compared with2 ko mice. Efflux was similar to that seen
in 2 het mice, suggesting that 2 tr(CT) mice express physio-
logically relevant levels of high-affinity nAChR (Fig. 3A). There
Figure 1. Transgenic mice with region-specific expression of2 subunit-containing nAChRs. Mice from three transgenic lines carrying the NSE promoter driving expression of the tetracycline
transactivator (NSE-tTA) (Chen et al., 1998; Kelz et al., 1999) were crossed with mice carrying the TetOp promoter driving the2 subunit (TetOp-2) on a2 ko background. [ 125I]A85380 binding
is shown in2 het,2 ko, and three lines of2 tr mice (CT, VN, and VTA). Bregma coordinates are shown for the four levels (Paxinos and Franklin, 1997).
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was no increase in [ 86Rb] efflux in cortical synaptosomes from
2 tr(CT) mice above levels seen in 2 ko mice, demonstrating
that nicotinic binding in this brain region is on cell bodies rather
than neuronal terminals. Furthermore, no release was seen in
striatum or hippocampus of 2 tr(CT) mice, as expected from
the lack of nicotinic binding in these brain areas.
Both GABAergic and glutamatergic terminals in the thalamus
express high-affinity nAChRs in wild-type mice. We therefore
measured [ 3H]GABA release from synaptosomes in response to
treatment with 30 M nicotine to identify the neuronal subtypes
expressing functional high-affinity nAChRs in 2 tr(CT) mice.
As expected, 2 wt and het mice showed increased [ 3H]GABA
release in response to nicotine treatment compared with 2 ko
mice (Lu et al., 1998). In contrast, 2 tr(CT) mice show no in-
creased GABA release over the level seen in 2 ko mice in any of
the brain areas tested (Fig. 3B). This implies that these transgenic
mice do not express high-affinity nAChRs in GABAergic neu-
rons. Thus, nicotinic binding, in situ hybridization, and release
data together suggest that 2 tr(CT) mice express high-affinity
nAChRs in glutamatergic, layer VI cortical neurons projecting to
the thalamus that are functional and can regulate neurotransmit-
ter release from synaptic terminals (Turner and Salt, 1998).
Corticothalamic2 nAChR expression restores baseline
PA behavior
We tested PA behavior in 2 tr(CT) mice and compared these
mice with sibling controls of different genotypes (Fig. 4). In con-
trast to 2 ko mice, which showed hypersensitive PA learning
compared with control siblings (Picciotto et al., 1995), 2 tr(CT)
mice had PA performance similar to wild-type mice and had a
significantly shorter latency to enter the dark chamber than2 ko
mice (Fig. 4). Thus, restricted expression of 2 subunit-
containing receptors to corticothalamic efferents is sufficient for
normal PA behavior.
We showed previously that nicotine is ineffective in improv-
ing PA performance in 2 ko mice (Picciotto et al., 1995). In the
current study, although nicotine was able to enhance PA perfor-
mance in wild-type mice [saline, 23.7  5.2 sec (n  17); nico-
tine, 56.4  16.8 sec (n  9); Newman–Keuls test; p  0.05], it
had no effect on 2 tr(CT) mice [saline, 31.8 6.6 sec (n 29);
nicotine, 26.7  1.6 sec (n  11)]. Thus, expression of high-
Figure 2. 2 subunit-containing nAChRs are expressed in the cortex and thalamus of 2
tr(CT) mice. A, Quantitiative epibatidine binding in microdissected brain regions of2 wt, het,
ko, and2 tr(CT) transgenic mice (n3 for each genotype). ANOVA showed a significant effect
of genotype on binding ( p 0.0001). Post hoc Newman–Keuls tests showed the2 wt and
2 het mice to be different from each other and all other genotypes for all brain areas ( p
0.05). The2 tr(CT) mice had greater binding than2 ko mice in the cortex and thalamus ( p
0.05). Binding in the hippocampus (Hipp.) and striatum did not differ between2 tr(CT) and
2 ko mice ( p 0.05). B, In situ hybridization with an antisense riboprobe against the large
intracellular loop region of the 2 subunit at the level of the thalamus (bregma1.10 mm)
and prefrontal cortex (bregma1.70 mm). Arrows point to the thalamus and layer VI of the
cortex.
Figure 3. 2 tr(CT) mice have functional expression of 2 subunit-containing nAChRs on
thalamic terminals of cortical projection neurons. A, Effect of genotype on nicotine-evoked
rubidium efflux (30M nicotine) from synaptosomal preparations of microdissected brain re-
gions (n 4 for each genotype). ANOVA showed a significant effect of genotype on [ 86Rb]
efflux in all brain areas ( p 0.0001). Post hoc Newman–Keuls tests showed the2 wt mice to
be different from all other genotypes in all brain areas ( p 0.05). The2 tr(CT) mice differed
from2 ko mice only in the thalamus ( p 0.05).2 tr(CT) did not differ from2 het mice in
[ 86Rb]efflux from thalamic synaptosomes ( p  0.05). B, Effect of genotype on nicotine-
evoked GABA release. [ 3H]GABA release was measured in response to a 12 sec exposure to 30
M nicotine in four brain regions (n4 for each genotype). ANOVAs of each brain area showed
a significant genotype effect on nicotine evoked [ 3H]GABA release in all brain areas ( p 
0.0001). Post hoc Newman–Keuls tests showed the2 wt and2 het mice to be different from
all other genotypes in all brain areas ( p 0.05). There was no increase in [ 3H]GABA release in
the2 tr(CT) compared with2 ko mice in any brain area ( p 0.05). No significant differ-
ences were seen for baseline release for any genotype in any brain area. Hipp., Hippocampus.
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affinity nAChRs on corticothalamic neurons rescues baseline
performance, although it is not sufficient to restore nicotine-
mediated enhancement of PA. These data suggest that nAChRs in
other brain regions, such as the amygdala, striatum, or hip-
pocampus, may be critical for the nicotine-mediated enhance-
ment of PA learning.
The restored baseline PA learning in 2 tr(CT) mice was at-
tributable to 2 subunit expression rather than transgene inser-
tion, because no difference in baseline PA behavior was seen in
mice carrying either the NSE-tTA transgene or the TetOp-2
transgene alone (Fig. 5A). The ability of transgenic expression
from a different locus to restore a phenotype altered in the 2 ko
mice also confirms that the original phenotype was not attribut-
able to effects of flanking genes surrounding the mutant allele
(Banbury Conference on Genetic Background in Mice, 1997; Bo-
livar et al., 2000). Furthermore, the difference in PA performance
in 2 tr(CT) mice cannot be explained by altered pain sensitivity
because no differences were seen in shock reactivity at intensities
similar to those used in PA training (Fig. 5B).
Developmental expression of2 nAChRs is critical for
baseline PA
One possible role for high-affinity nAChRs in thalamus could be
to modulate sensory processing through thalamus to cortex by
altering synaptic strength in glutamatergic neurons during devel-
opment. To determine whether high-affinity nAChRs act acutely
to regulate PA behavior in the adult or whether the receptors are
critical earlier in development, adult mice were administered 100
g/ml dox in their drinking water for 30 d to abolish expression
of high-affinity nAChRs in 2 tr(CT) mice (Fig. 6A). dox adminis-
tration had no effect on PA performance of mice of any genotype
(Fig. 6B). These data suggest that expression of 2 subunit-
containing nAChRs in corticothalamic efferents during develop-
ment results in a long-lasting alteration of this pathway that facili-
tates PA learning in the adult.
Discussion
We generated transgenic mice with inducible, region-specific ex-
pression of 2 subunit-containing nAChRs in corticothalamic
projection neurons. Using these mice, we showed that alterations
in neurotransmission through nAChRs during development can
affect PA performance in the adult. Nicotine treatment during
development is known to have neurodevelopmental and behav-
ioral consequences. In humans, maternal smoking has been as-
sociated with babies of lower birth weight, increased risk of sud-
den infant death syndrome, and increased risk of psychiatric
disorders in childhood and adolescence (Ernst et al., 2001), in-
cluding ADHD (Milberger et al., 1996; Milberger et al., 1998).
Cognitive impairments and hyperactivity have also been reported
in animals exposed to nicotine during development (Genedani et
al., 1983; Sorenson et al., 1991; Pennington et al., 1994; Shacka et
al., 1997). A blunting of both cholinergic and catecholaminergic
function is also seen in rats prenatally exposed to nicotine (Na-
varro et al., 1988, 1989; Oliff and Gallardo, 1999). Thus, expres-
sion of nAChRs during prenatal and postnatal development is
likely to be critical for normal cognitive behavior in the adult.
The first 2 weeks of life are a critical period for maturation of
glutamatergic synapses on corticothalamic neurons, with target-
ing of glutamate receptor subunits such as mGluR1a to the distal
dendrites of these synapses during the second postnatal week of
rat development (Liu et al., 1998). Chronic nicotine treatment at
this time has been shown to enhance glutamatergic (NMDA
receptor-mediated) transmission in the neocortex of rats (Ara-
makis and Metherate, 1998), resulting in a subsequent increase in
Figure 4. Expression of 2 subunit-containing receptors in corticothalamic terminals is
sufficient for normal baseline PA performance. PA performance was evaluated in wild-type (2
het and2 wt),2 ko, and2 tr(CT) mice [wild type, n 17;2 ko, n 21;2 tr(CT), n
29]. A repeated-measures ANOVA of the baseline PA performance with day (testing vs training)
as the within-subject variable and genotype [wild type,2 ko, and2 tr(CT)] as the between-
subject variable revealed an interaction of day and genotype (F(2,64) 4.311; p 0.05). Post
hoc Newman–Keuls tests showed the 2 ko mice to have a longer latency to enter the dark
compartment on testing than the wild-type and2 tr(CT) mice ( p 0.05).
Figure 5. The PA phenotype is not attributable to transgene insertion or alteration of shock
sensitivity. A, The insertion of the individual transgenes on the2 het or2 ko backgrounds
does not affect PA performance.2 het and2 ko mice with either the TetOp-2 or NSE-tTA
transgene alone were tested for PA behavior (2 het/TetOp-2, n 8;2 het/NSE-tTA, n
9;2 ko/TetOp-2, n 15;2 ko/NSE-tTA, n 12). Repeated-measures ANOVA with day
(testing vs training) as the within-subject variable and genotype (2 het vs2 ko) and trans-
gene (TetOp-2 vs NSE-tTA) as between-subject variables showed an interaction of day and
genotype (F(1,40) 9.015; p 0.01) but no main effect or interaction with single transgenes.
B, The altered PA phenotype is not a result of differential shock reactivity. Mice of different
genotypes [2 wt and 2 het, 2 ko and 2 tr(CT)] were tested for response to increasing
levels of shock. (2 wt and 2 het were combined as “wild types” for subsequent analysis).
Mean lowest shock that evoked the responses flinch, run, and vocalize for each of the three
genotypes (n 7 per genotype) is plotted. ANOVA showed no effect of genotype ( p 0.05 in
all cases).
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NMDA receptor subunit NR2A mRNA expression in layer VI of
the auditory cortex that lasts for 2 weeks (Hsieh et al., 2002).
These data suggest that expression of high-affinity nAChRs dur-
ing this period of development can affect maturation of glutama-
tergic synapses. In rat, the NSE promoter drives expression early
in the development of layer VI neurons and remains on through-
out development, with a dip on postnatal day 10, before rising
again to adult levels by day 20 (Hamre et al., 1989). Our data
suggest that the presence of 2 subunit-containing nAChRs dur-
ing these critical periods of synaptogenesis is essential for the
long-term modulation of PA performance.
The nicotine-induced enhancement of PA learning in adult
mice is not mediated by nAChRs on corticothalamic efferents,
however. We hypothesize that nAChRs in other brain regions are
critical for the effect of nicotine on PA learning in adulthood, and
potential brain regions that could be explored include the amyg-
dala (Riekkinen et al., 1993), striatum (Sandberg et al., 1984;
Giordano et al., 1998), or hippocampus (Pope et al., 1985; Bailey
et al., 1986), all of which have been identified as critical sites for
plastic changes associated with consolidation of PA learning
(McGaugh et al., 1996).
High-affinity nAChRs are normally expressed throughout the
brain and are likely to affect the development and function of
synaptic activity in many brain areas. Mutations in the4 and2
subunits of the nAChR in several human families result in auto-
somal dominant nocturnal frontal lobe epilepsies (Sutor and
Zolles, 2001), which have been associated with an increased prob-
ability of learning and developmental disorders (Gunduz et al.,
1999; Verrotti et al., 2000). It should be noted, however, that it is
unclear whether the cognitive impairment in these patients re-
sults directly from altered nAChR activity during development or
indirectly from repeated seizures, which are known to cause cog-
nitive impairment. We showed that mutation of the2 subunit in
mice results in abnormal sensitivity to PA learning and have iden-
tified corticothalamic efferents as the anatomical locus for this
effect. Abnormalities in nAChRs in human subjects may also
result in developmental changes in corticothalamic signaling that
could affect emotional learning. Prenatal exposure to nicotine in
humans may desensitize and functionally downregulate high-
affinity nAChRs, as is seen with chronic nicotine exposure in
mice (Marks et al., 1993; Zachariou et al., 2001). Thus, chronic
exposure to nicotine during development could alter nicotinic
neurotransmission in corticothalamic circuits and lead to inap-
propriate emotional learning during adulthood.
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